BACKGROUND AND OBJECTIVES: To compare the clinical features and biochemical profile in DKA. To assess the response in the patients with standard treatment of DKA. Clinical descriptions of polyuric states resembling diabetes mellitus have been described in the Ebers papyrus of Egypt in 15th century BC. 1,2 Ayurvedic literature from the times of Charaka and Sushrutha, the ancient Indian physicians identified two forms of "MadhuMeha" (Honeyed Urine) in 400 BC. 3 John Rolo of England in 1797 was one of 1st who coined the term diabetes mellitus. William Prout of England described diabetic coma during 1810-20. In 1886, Dreschfeld8 described DKA and HHNS (Hyper osmolar Hyperglycemic Non-ketotic Syndrome). In 1922 Banting, Best, Collip and Macleod isolated and clinically used insulin and later won Nobel prize for that memorable invention. SETTING: Inpatients of king George Hospital attached to Andhra Medical College, Visakhapatnam. METHODS: Diagnosis of diabetic ketoacidosis was made according to the inclusion criteria. Hyperglycemia >250 mg/dl, acidosis with blood pH <7.3, serum bicarbonate <15 mEq/l, urine positive for ketones. RESULTS: Of the 100 patients admitted for diabetic ketoacidosis; 84 had type 2 diabetes (84%) and 16(16%) were type I diabetes. Average age at the time of presentation was 42.9±12.9 years. The commonest precipitating factor was infection (56%) followed by other factors (28%) and irregular treatment (16%). The most common clinical features at the time of presentation were vomiting, abdominal pain, acidotic breathing and dehydration. The values for RBS, HCO3, and pH were 355.3±69.1, 14.9±3.4 and 7.2±0.1 respectively. INTERPRETATION AND CONCLUSION: Most common precipitating factors are infection and omission of insulin or irregular treatment. Most common clinical features at the time of presentation are vomiting, abdominal pain, dehydration, acidotic breathing and tachycardia. Mortality rate in diabetic ketoacidosis is 4% and the most notable predictors of poor prognosis are; severity of altered sensorium.
AIM: To study the role of risk factors in Cerebrovascular Stroke. MATERIALS AND METHODS: 60 patients who were admitted with cerebro vascular stroke over 2 months of period from 1 st November to 31 st December 2014 in King George Hospital AMC, Visakhapatnam studied retrospectively. RESULTS: In this study majority of cases (43) are males contributing to 71.7%. The stroke is more prevalent in the middle age.The most common presentation other than weakness is altered sensorium in 21 cases (33.6%). Among 60 cases 40% (24) of cases had right sided lesion, 60% (36) of cases had left sided lesion. Hypertension is more commonly associated with haemorrhagic (26.7%) than ischaemic strokes. Smoking is more responsible for ischaemic strokes (30%) than haemorrhagic. Alcohol is found to be the most significant risk factor in both types of strokes (61.7%). Diabetes is present in 9 cases (15%). Hyperlipidaemia was found more significantly among males (20%) both in ischaemic stroke (13.3%) and haemorrhagic stroke (6.7%).Majority of cases that is 45 cases (75%) have multiple risk factors. CONCLUSION: Acute stroke is a heterogeneous condition with respect to prognosis. Though the stroke related mortality is steadily declining in the west, it has been rising in India. The most commonly affected age group is 50-59 years which is the golden period in one's life. Modifiable risk factors should be strictly corrected especially those who also have fixed risk factors. Probability of stroke incidence increases with the presence of multiple abnormalities in the risk profile. The recognition of multiple risk factors for the stroke at early stage may help both patient and physician to prevent further complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.